Opinion
Video
Author(s):
Experts on bladder cancer discuss exciting new agents and treatment strategies and where they can potentially fit into urothelial cancer treatment paradigms.
Fox Chase Cancer Center Researchers Review Guidelines for Therapies Given to Melanoma Patients Before and After Initial Treatment
Blinatumomab-Based Regimens Enhance and Refine the B-ALL Treatment Paradigm: With Ryan Cassaday, MD
Fox Chase Cancer Center’s Dr. Eric Goodlev Named a Fellow of the American Academy of Hospice and Palliative Medicine
Zanubrutinib Leads the Way for Advancements in CLL Management: With Mazyar Shadman, MD, MPH
Fox Chase Cancer Center Researchers Present Data on Use of Checkpoint Inhibitors and Test Measuring Their Benefit to Patients
NKT2152 Ushers in a New Era of HIF-2α Inhibition in Pretreated Advanced ccRCC
Dr Hamid on the Potential for Cancer Vaccines in Melanoma
Dr Orloff on Treatment Strategies for Rapidly Progressing Uveal Melanoma
Dr Faries on Emerging CAR T-Cell and TCR Cell Therapies in Melanoma
Targeted Therapies for NSCLC With Nonclassical EGFR Mutations Grow Increasingly Personalized